Close Menu

NEW YORK — Becton Dickinson said on Wednesday that it has received CE-IVD marking for its point-of-care BD Veritor Plus SARS-CoV-2 antigen test.

The test will be available in Europe by the end of October, BD said.

The assay operates on the Franklin Lakes, New Jersey-based company's portable BD Veritor Plus System and provides results in 15 minutes. BD aims to produce 8 million of the SARS-CoV-2 tests a month by October and 12 million tests a month by March 2021.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.